CD4 and neoplasm: Moreover, CTLA-4 expression on conventional CD4+(CD8−)CD25+FOXP3+ Tregs was substantially downregulated by SDT (Fig. 7; Supplementary Table S2) – by two-fold in both target and off-target tumours (large effect size for both).